Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter

Biomedicines. 2023 Jul 13;11(7):1979. doi: 10.3390/biomedicines11071979.

Abstract

Background: Pediatric inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disease that affects both children and adolescents. Symptoms can significantly affect a child's growth, development, and quality of life, making early diagnosis and effective management crucial. This study focuses on treatment-naïve pediatric IBD patients and their immediate families to identify the role of the microbiome in disease onset.

Methods: Nine families with pediatric IBD were recruited, comprising seven drug-naïve Crohn's disease (CD) patients and two drug-naïve ulcerative colitis (UC) patients, as well as twenty-four healthy siblings/parents. Fecal samples were collected for 16S ribosomal RNA gene sequencing and bioinformatics analysis.

Results: We identified patterns of dysbiosis and hallmark microbial taxa among patients who shared ethnic, habitual, and dietary traits with themselves and their families. In addition, we examined the impact of the disease on specific microbial taxa and how these could serve as potential biomarkers for early detection.

Conclusions: Our results suggest a potential role of maternal factors in the establishment and modulation of the early life microbiome, consistent with the current literature, which may have implications for understanding the etiology and progression of IBD.

Keywords: Crohn’s disease; family; inflammatory bowel disease; microbiome; ulcerative colitis.

Grants and funding

S.F., G.K. (George Karamanolisand) and M.G. are funded by the project 2020EOMIFNEp3 financed by the Hellenic Idiopathic Inflammatory Bowel Disease Study Group. N.D. and G.K. (George Kolios) are funded by the project IMPReS (MIS 5047189) financed by the Program “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014–2020) and co-financed by Greece and the European Union (European Regional Development Fund).